Skip to content

Clinical trials

Observational Depressive Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Depressive Disorder Phase: Observational Country / region: United States Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20052
20061
20072
20081
20092
20104
20112
20171
20182
20195
20204
20211
20221
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Recruiting3
Enrolling by invitation2
Unknown status2
Suspended1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Mental Health (NIMH)8
Stanford University5
VA Office of Research and Development4
Massachusetts General Hospital2
Medibio Limited2
ProgenaBiome2
University of Virginia2
Brown University1
Duke University1
Freeman-Sheldon Research Group, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Depressive Disorder41
Anxiety Disorders13
Major Depressive Disorder13
Bipolar Disorder8
Mental Disorders5
Mood Disorders5
Stress Disorders, Post-Traumatic5
Alcoholism3
Alcohol-Related Disorders2
Autism Spectrum Disorder2

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.